news

In the Media

2024-11-18 // Operating Principles for Impact Management 2024 Disclosure Statement

Go to Article

2024-05-07 // Memo Therapeutics Raises CHF 20 Million

Go to Article

2023-11-16 // Adjuvant Capital OPIM Disclosure Statement

Go to Article

2023-10-13 // Biden administration awards $500M for new COVID treatments

Go to Article

2023-10-11 // Pharma-backed MinervaX raises €54M as it aims to move its group B Streptococcus vaccine into PhIII

Go to Article

2023-10-09 // Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm

Go to Article

Adjuvant seeks out the most innovative life sciences companies in the world.

See our Portfolio